Skip to main content
. 2022 Apr 29;11(3):229–249. doi: 10.12997/jla.2022.11.3.229

Table 1. Association between serum vitamin D and circulatory EPC levels.

References No. of subjects Subject characteristics Serum vitamin D concentration Levels of EPCs in circulation Associations observed
Mikirova et al.135 n=41 Healthy adults <40 ng/mL Mean % 0.045 Positive correlation between serum VitD concentration and circulatory EPC level.
>40 ng/mL 0.068
<30 ng/mL 0.046
>30 ng/mL 0.060
Yiu et al.134 n=96, VitD deficient Diabetic <20 ng/mL CD34+/KDR+ (%): 0.746±0.465 Circulatory level of CD133+/KDR+ EPC found to be positively correlated with VitD deficiency and insufficiency group.
CD133+/KDR+ (%): 0.219±0.189
n=115, VitD insufficient <30 ng/mL CD34+/KDR+ (%): 0.628±0.354
CD133+/KDR+ (%): 0.283±0.197
n=69, VitD sufficient ≥30 ng/mL CD34+/KDR+ (%): 0.747±0.412
CD133+/KDR+ (%): 0.364±0.172
Chan et al.139 n=297 CVD (coronary artery disease, ischemic stroke) <20 ng/mL log, unit (×10−3/mL) 0.97±0.31 Positive association between serum 25(OH)D and CD34+KDR+, CD133+KDR+ EPC.
20–29 ng/mL 1.05±0.42
30–39 ng/mL 1.08±0.41
≥40 ng/mL 1.15±0.39
Gurses et al.140 n=27, control group Premenopausal women with VitD deficient 34.40±10.30 ng/mL (for control group) CD34+/KDR+ EPC (/uL): 64.50±17.10 Positive correlation between baseline VitD level and circulatory level of CD34+/KDR+, CD133+/KDR+ cells.
CD133+/KDR+ EPC (/uL): 49.40±23.10
n=31, VitD deficient group 10.60±4.70 ng/mL (for VitD deficient group) CD34+/KDR+ EPC (/uL): 26.20±20.50
CD133+/KDR+ EPC (/uL): 27.40±18.50
Berezin et al.137 n= 10, 25(OH)D3 MetS without known CVD >100 nmol/L CD14+CD309+Tie2+ cells/uL 0.039 (0.032–0.047) Positive association
n=12, 25(OH)D3 50–100 nmol/L 0.035 (0.028–0.044) VitD deficiency significant predictor for reduced circulatory proangiogenic progenitor cells as CD14+CD309+Tie2+.
n= 14, 25(OH)D3 level 30–50 nmol/L 0.030 (0.022–0.041)
n=11, 25(OH)D3 <30 nmol/L 0.028 (0.016–0.033)

VitD, vitamin D; EPC, endothelial progenitor cell; CD, cluster differentiation; KDR, kinase insert domain receptor; Tie2, tyrosine kinase receptor 2; 25(OH)D, 25-hydroxyvitamin D; MetS, metabolic syndrome.

HHS Vulnerability Disclosure